AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice

Molecular Therapy

Volumn 19, Issue 10, 2011, Pages 1826-1832

  Bostick, Brian ^a   Shin, Jin Hong ^a   Yue, Yongping ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DYSTROPHIN; MICRODYSTROPHIN; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DUCHENNE CARDIOMYOPATHY; ELECTROCARDIOGRAM; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; HEART DEATH; HEART FUNCTION; HEART HEMODYNAMICS; HEART PERFORMANCE; HEART PROTECTION; MOUSE; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

ADENO-ASSOCIATED VIRUS; MUS;

EID: 80053576108     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.154     Document Type: Article

References (48)

1. American Academy of Pediatrics, Section on Cardiology and Cardiac Surgery (2005). Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 116: 1569-1573.
2. Duan, D (2006). Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum Mol Genet 15 Spec No 2: R253-R261. (Pubitemid 44446801)
3. Shin, J-H, Bostick, B, Yue, Y, and Duan, D (2010). Duchenne cardiomyopathy gene therapy. In: Duan, D (ed). Muscle Gene Therapy. Springer Science + Business Media, LLC: New York. pp 141-162.
4. Gregorevic, P, Blankinship, MJ, Allen, JM, Crawford, RW, Meuse, L, Miller, DG et al. (2004). Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10: 828-834. (Pubitemid 39070856)
5. Wang, Z, Zhu, T, Qiao, C, Zhou, L, Wang, B, Zhang, J et al. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23: 321-328. (Pubitemid 41094420)
6. Pacak, CA, Mah, CS, Thattaliyath, BD, Conlon, TJ, Lewis, MA, Cloutier, DE et al. (2006). Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 99: e3-e9. (Pubitemid 44255502)
7. Bostick, B, Ghosh, A, Yue, Y, Long, C and Duan, D (2007). Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther 14: 1605-1609. (Pubitemid 350056232)
8. England, SB, Nicholson, LV, Johnson, MA, Forrest, SM, Love, DR, Zubrzycka-Gaarn, EE et al. (1990). Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343: 180-182.
9. Fanin, M, Freda, MP, Vitiello, L, Danieli, GA, Pegoraro, E and Angelini, C (1996). Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size? Muscle Nerve 19: 1154-1160. (Pubitemid 26274966)
10. Yue, Y, Liu, M and Duan, D (2006). C-terminal-truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double-knockout mice. Mol Ther 14: 79-87. (Pubitemid 43922138)
11. Gregorevic, P, Blankinship, MJ, Allen, JM and Chamberlain, JS (2008). Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice. Mol Ther 16: 657-664. (Pubitemid 351426166)
12. Gregorevic, P, Allen, JM, Minami, E, Blankinship, MJ, Haraguchi, M, Meuse, L et al. (2006). rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12: 787-789. (Pubitemid 44050067)
13. Bostick, B, Yue, Y, Long, C, Marschalk, N, Fine, DM, Chen, J et al. (2009). Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 17: 253-261.
14. Yue, Y, Skimming, JW, Liu, M, Strawn, T and Duan, D (2004). Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet 13: 1669-1675. (Pubitemid 39136722)
15. Yue, Y, Li, Z, Harper, SQ, Davisson, RL, Chamberlain, JS and Duan, D (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108: 1626-1632. (Pubitemid 37187791)
16. Danialou, G, Comtois, AS, Dudley, R, Karpati, G, Vincent, G, Des Rosiers, C et al. (2001). Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J 15: 1655-1657.
17. Van Erp, C, Loch, D, Laws, N, Trebbin, A and Hoey, AJ (2010). Timeline of cardiac dystrophy in 3-18-month-old MDX mice. Muscle Nerve 42: 504-513.
18. Quinlan, JG, Hahn, HS, Wong, BL, Lorenz, JN, Wenisch, AS and Levin, LS (2004). Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 14: 491-496. (Pubitemid 39141704)
19. Lefaucheur, JP, Pastoret, C and Sebille, A (1995). Phenotype of dystrophinopathy in old mdx mice. Anat Rec 242: 70-76.
20. Wehling-Henricks, M, Jordan, MC, Roos, KP, Deng, B and Tidball, JG (2005). Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 14: 1921-1933. (Pubitemid 41418029)
21. Bostick, B, Yue, Y, Long, C and Duan, D (2008). Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 102: 121-130.
22. Bostick, B, Yue, Y and Duan, D (2010). Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve 42: 600-603.
23. Bostick, B, Yue, Y, Lai, Y, Long, C, Li, D and Duan, D (2008). Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 19: 851-856.
24. Ghosh, A, Yue, Y, Shin, JH and Duan, D (2009). Systemic Trans-splicing adenoassociated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy. Hum Gene Ther 20: 1319-1328.
25. Townsend, D, Blankinship, MJ, Allen, JM, Gregorevic, P, Chamberlain, JS and Metzger, JM (2007). Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Mol Ther 15: 1086-1092. (Pubitemid 46813611)
26. Katz, MG, Swain, JD, White, JD, Low, D, Stedman, H and Bridges, CR (2010). Cardiac gene therapy: optimization of gene delivery techniques in vivo. Hum Gene Ther 21: 371-380.
27. Ly, HQ, Kawase, Y and Hajjar, RJ (2008). Advances in gene-based therapy for heart failure. J Cardiovasc Transl Res 1: 127-136.
28. Jefferies, JL, Eidem, BW, Belmont, JW, Craigen, WJ, Ware, SM, Fernbach, s.d. et al. (2005). Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112: 2799-2804. (Pubitemid 41641674)
29. Kaspar, RW, Allen, HD, Ray, WC, Alvarez, CE, Kissel, JT, Pestronk, A et al. (2009). Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy. Circ Cardiovasc Genet 2: 544-551.
30. Lai, Y, Yue, Y, Bostick, B, and Duan, D (2010). Delivering large therapeutic genes for muscle gene therapy. In: Duan, D (ed). Muscle Gene Therapy. Springer Science + Business Media, LLC: New York. pp 205-218.
31. Harper, SQ, Hauser, MA, DelloRusso, C, Duan, D, Crawford, RW, Phelps, SF et al. (2002). Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8: 253-261. (Pubitemid 34250103)
32. Wang, B, Li, J and Xiao, X (2000). Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci USA 97: 13714-13719.
33. Lai, Y, Thomas, GD, Yue, Y, Yang, HT, Li, D, Long, C et al. (2009). Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119: 624-635.
34. Trollet, C, Athanasopoulos, T, Popplewell, L, Malerba, A and Dickson, G (2009). Gene therapy for muscular dystrophy: current progress and future prospects. Expert Opin Biol Ther 9: 849-866.
35. Odom, GL, Gregorevic, P and Chamberlain, JS (2007). Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim Biophys Acta 1772: 243-262. (Pubitemid 46123917)
36. Muntoni, F, Di Lenarda, A, Porcu, M, Sinagra, G, Mateddu, A, Marrosu, G et al. (1997). Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy. Heart 78: 608-612. (Pubitemid 28034215)
37. Melacini, P, Fanin, M, Danieli, GA, Villanova, C, Martinello, F, Miorin, M et al. (1996). Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94: 3168-3175. (Pubitemid 26427483)
38. Melis, MA, Cau, M, Muntoni, F, Mateddu, A, Galanello, R, Boccone, L et al. (1998). Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. Eur J Paediatr Neurol 2: 255-261. (Pubitemid 28553033)
39. Melis, MA, Cau, M and Deidda, F (1998). Mutation of dystrophin gene in two families with X-linked dilated cardiomyopathy. Neuromuscul Disord 8: 244.
40. Arbustini, E, Diegoli, M, Morbini, P, Dal Bello, B, Banchieri, N, Pilotto, A et al. (2000). Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35: 1760-1768. (Pubitemid 30342854)
41. Melacini, P, Fanin, M, Danieli, GA, Fasoli, G, Villanova, C, Angelini, C et al. (1993). Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol 22: 1927-1934. (Pubitemid 23359655)
42. Nigro, G, Politano, L, Nigro, V, Petretta, VR and Comi, LI (1994). Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 4: 371-379. (Pubitemid 24280934)
43. Li, D, Long, C, Yue, Y and Duan, D (2009). Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet 18: 1209-1220.
44. Chamberlain, JS, Metzger, J, Reyes, M, Townsend, D and Faulkner, JA (2007). Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21: 2195-2204. (Pubitemid 47026454)
45. Lawlor, MW, Read, BP, Edelstein, R, Yang, N, Pierson, CR, Stein, MJ et al. (2011). Inhibition of activin receptor type IIB increases strength and lifespan in myotubularindeficient mice. Am J Pathol 178: 784-793.
46. Hakim, CH, Grange, RW and Duan, D (2011). The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2-to 20-mo-old mdx mice. J Appl Physiol 110: 1656-1663.
47. Bostick, B, Yue, Y and Duan, D (2011). Phenotyping cardiac gene therapy in mice. Methods Mol Biol 709: 91-104.
48. Nigro, G, Comi, LI, Politano, L, and Nigro, G (2004). Cardiomyopathies associated with muscular dystrophies. In: Engel, A and Franzini-Armstrong C (eds). Myology: Basic and Clinical. 3rd edn., vol. 2. McGraw-Hill, Medical Pub. Division: New York. pp 1239-1256.